These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 33676792

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
    Smolle MA, van de Sande M, Hayes A, Bergovec M, Smith HG, Liegl-Atzwanger B, Tunn PU, Niethard M, Windhager R, Szkandera J, Leithner A.
    Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG.
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [Abstract] [Full Text] [Related]

  • 5. Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall.
    Gronchi A, Verderio P, De Paoli A, Ferraro A, Tendero O, Majò J, Martin J, Comandone A, Grignani G, Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Palassini E, Stacchiotti S, Ferrari S, Fiore M, Casali PG.
    Ann Oncol; 2013 Mar; 24(3):817-23. PubMed ID: 23110811
    [Abstract] [Full Text] [Related]

  • 6. Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk.
    Wang J, Song Y, Liu X, Jin J, Wang W, Yu Z, Liu Y, Li N, Fang H, Ren H, Tang Y, Tang Y, Chen B, Lu N, Qi S, Wang S, Li Y.
    Cancer Med; 2019 Mar; 8(3):902-909. PubMed ID: 30740916
    [Abstract] [Full Text] [Related]

  • 7. Preoperative radiotherapy with concomitant chemotherapy in extremity soft tissue sarcomas: long-term results of a single center.
    Yilmaz U, Kamer S, Kaya H, Sabah D, Sanli UA, Tamsel I, Yaman B, Akalin T, Anacak Y.
    Strahlenther Onkol; 2023 Jun; 199(6):585-594. PubMed ID: 36725697
    [Abstract] [Full Text] [Related]

  • 8. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
    Chowdhary M, Chowdhary A, Sen N, Zaorsky NG, Patel KR, Wang D.
    Cancer; 2019 Nov 01; 125(21):3801-3809. PubMed ID: 31490546
    [Abstract] [Full Text] [Related]

  • 9. The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric series.
    Stoeckle E, Michot A, Rigal L, Babre F, Sargos P, Henriques de Figueiredo B, Brouste V, Italiano A, Toulmonde M, Le Loarer F, Kind M.
    Eur J Surg Oncol; 2017 Jun 01; 43(6):1117-1125. PubMed ID: 28202211
    [Abstract] [Full Text] [Related]

  • 10. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
    Kobus M, Roohani S, Ehret F, Flörcken A, Striefler JK, Brandes F, Märdian S, Rau D, Wittenberg S, Öllinger R, Kaul D.
    Radiat Oncol; 2022 Aug 08; 17(1):139. PubMed ID: 35941656
    [Abstract] [Full Text] [Related]

  • 11. Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy.
    Bedi M, King DM, Shivakoti M, Wang T, Zambrano EV, Charlson J, Hackbarth D, Neilson J, Whitfield R, Wang D.
    Radiat Oncol; 2013 Mar 14; 8():60. PubMed ID: 23497372
    [Abstract] [Full Text] [Related]

  • 12. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
    Mahmoud O, Dosch A, Kwon D, Pitcher JD, Conway S, Benedetto P, Fernandez G, Trent J, Temple HT, Wolfson AH.
    Am J Clin Oncol; 2016 Oct 14; 39(5):528-34. PubMed ID: 24879472
    [Abstract] [Full Text] [Related]

  • 13. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
    Chou YS, Liu CY, Chen WM, Chen TH, Chen PC, Wu HT, Chiou HJ, Shiau CY, Wu YC, Liu CL, Chao TC, Tzeng CH, Yen CC.
    J Surg Oncol; 2012 Aug 01; 106(2):155-61. PubMed ID: 22297812
    [Abstract] [Full Text] [Related]

  • 14. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma.
    Willis F, Schimmack S, Uhl M, Haefner MF, Mechtersheimer G, Hinz U, Schmidt T, Debus J, Fröhling S, Schneider M.
    Eur J Surg Oncol; 2020 May 01; 46(5):905-913. PubMed ID: 31892479
    [Abstract] [Full Text] [Related]

  • 15. Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.
    Harati K, Goertz O, Pieper A, Daigeler A, Joneidi-Jafari H, Niggemann H, Stricker I, Lehnhardt M.
    Oncologist; 2017 Nov 01; 22(11):1400-1410. PubMed ID: 28739867
    [Abstract] [Full Text] [Related]

  • 16. Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.
    Canter RJ, Borys D, Olusanya A, Li CS, Lee LY, Boutin RD, Christensen SD, Tamurian RM, Monjazeb AM.
    Ann Surg Oncol; 2014 May 01; 21(5):1616-23. PubMed ID: 24554062
    [Abstract] [Full Text] [Related]

  • 17. Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall.
    Rutkowski P, Trepka S, Ptaszynski K, Kołodziejczyk M.
    Clin Orthop Relat Res; 2013 Mar 01; 471(3):860-70. PubMed ID: 22972658
    [Abstract] [Full Text] [Related]

  • 18. Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model.
    Willeumier JJ, Rueten-Budde AJ, Jeys LM, Laitinen M, Pollock R, Aston W, Dijkstra PD, Ferguson PC, Griffin AM, Wunder JS, Fiocco M, van de Sande MA.
    BMJ Open; 2017 Feb 14; 7(2):e012930. PubMed ID: 28196946
    [Abstract] [Full Text] [Related]

  • 19. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH.
    J Surg Res; 2020 Jan 14; 245():577-586. PubMed ID: 31494391
    [Abstract] [Full Text] [Related]

  • 20. Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution.
    Muratori F, Frenos F, Bettini L, Matera D, Mondanelli N, Scorianz M, Cuomo P, Scoccianti G, Beltrami G, Greto D, Livi L, Baldi G, Roselli G, Capanna R, Campanacci DA.
    J Orthop Sci; 2018 Nov 14; 23(6):1038-1044. PubMed ID: 30007495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.